Notify me when Tamarack Advisers, LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | 1 | $2,120,279 | -$45,396,269 | -$45,396,269 | STRM | 13F-HR | 08 Feb 2024, 17:42 | |
| Q3 2023 | 40 | $154,421,847 | +$105,599,350 | -$261,126,421 | -$155,527,071 | VTRS, BDX, MDRX, MCK, STRM | 13F-HR | 15 Nov 2023, 21:55 |
| Q2 2023 | 34 | $323,565,800 | +$222,508,791 | -$19,278,655 | +$203,230,136 | SPY, TLT, VTRS, MDRX, PHR | 13F-HR | 09 Aug 2023, 18:28 |
| Q1 2023 | 38 | $273,551,417 | +$115,903,270 | -$19,221,681 | +$96,681,589 | VTRS, MDRX, PHR, STRM, COLL | 13F-HR | 10 May 2023, 18:06 |
| Q4 2022 | 36 | $194,194,659 | +$87,080,254 | -$23,478,515 | +$63,601,739 | MDRX, VTRS, PHR, CERS, COLL | 13F-HR | 10 Feb 2023, 18:09 |
| Q3 2022 | 46 | $170,309,009 | +$47,816,560 | -$26,229,236 | +$21,587,324 | LNTH, MDRX, PCRX, PRGO, THC | 13F-HR | 14 Nov 2022, 18:12 |
| Q2 2022 | 41 | $172,833,015 | +$62,881,999 | -$18,846,887 | +$44,035,112 | CI, LNTH, CERS, PCRX, THC | 13F-HR | 15 Aug 2022, 18:39 |
| Q1 2022 | 45 | $204,435,670 | +$67,033,096 | -$49,878,090 | +$17,155,006 | CI, PCRX, LNTH, MRK, BVS | 13F-HR | 11 May 2022, 15:28 |
| Q4 2021 | 48 | $243,144,067 | +$90,512,979 | -$114,866,015 | -$24,353,036 | THC, PCRX, MDTXXXX, BVS, SIBN | 13F-HR | 11 Feb 2022, 18:04 |
| Q3 2021 | 36 | $312,410,000 | +$58,428,675 | -$83,433,811 | -$25,005,136 | HSIC, RIGL, MDTXXXX, PCRX, PDCO | 13F-HR | 10 Nov 2021, 18:30 |
| Q2 2021 | 40 | $348,817,000 | +$68,220,361 | -$235,432,442 | -$167,212,081 | MDTXXXX, RIGL, HSIC, PCRX, TPB | 13F-HR | 12 Aug 2021, 20:08 |
| Q1 2021 | 54 | $481,778,000 | +$128,173,955 | -$161,496,518 | -$33,322,563 | PCRX, MDTXXXX, RIGL, PDCO, TPB | 13F-HR | 11 May 2021, 20:31 |
| Q4 2020 | 45 | $479,955,000 | +$141,712,817 | -$20,661,132 | +$121,051,685 | PCRX, MDTXXXX, UTHR, RIGL, NUAN | 13F-HR | 09 Feb 2021, 16:32 |
| Q3 2020 | 35 | $324,480,000 | +$62,500,269 | -$56,671,552 | +$5,828,717 | PCRX, MDTXXXX, HOLX, PRGO, RIGL | 13F-HR | 10 Nov 2020, 19:19 |
| Q2 2020 | 33 | $359,176,000 | +$110,222,121 | -$56,751,201 | +$53,470,920 | PCRX, DGX, PRGO, UTHR, HOLX | 13F-HR | 10 Aug 2020, 18:07 |
| Q1 2020 | 31 | $264,078,000 | +$82,953,551 | -$98,858,531 | -$15,904,980 | DGX, MDTXXXX, ATRC, MDRX, PRGO | 13F-HR | 14 May 2020, 13:48 |
| Q4 2019 | 29 | $437,664,000 | +$88,139,921 | -$44,677,510 | +$43,462,411 | MDTXXXX, BIO, MDRX, ATRC, PCRX | 13F-HR | 10 Feb 2020, 19:48 |
| Q3 2019 | 31 | $383,785,000 | +$91,203,781 | -$10,026,523 | +$81,177,258 | MDRX, MDTXXXX, BIO, PCRX, PTLA | 13F-HR | 05 Nov 2019, 14:42 |
| Q2 2019 | 20 | $319,247,000 | +$101,005,151 | -$19,062,707 | +$81,942,444 | MDRX, MDTXXXX, BIO, PCRX, SRCL | 13F-HR | 12 Aug 2019, 16:58 |
| Q1 2019 | 22 | $251,884,000 | +$66,419,792 | -$16,265,352 | +$50,154,440 | MDRX, MDTXXXX, SRCL, PTLA, LNTH | 13F-HR | 13 May 2019, 15:29 |
| Q4 2018 | 20 | $222,800,000 | +$43,081,215 | -$12,037,084 | +$31,044,131 | MDRX, MDTXXXX, NUVA, ATRC, NXTM | 13F-HR | 11 Feb 2019, 16:25 |
| Q3 2018 | 29 | $316,816,000 | +$63,663,582 | -$14,324,046 | +$49,339,536 | NUVA, LH, MDRX, MDTXXXX, SRCL | 13F-HR | 13 Nov 2018, 12:26 |
| Q2 2018 | 28 | $264,345,430 | +$119,029,880 | -$1,814,821 | +$117,215,059 | MDTXXXX, NUVA, MDRX, LH, OPTN | 13F-HR | 14 Aug 2018, 12:53 |
| Q1 2018 | 27 | $210,233,000 | +$104,648,102 | -$17,507,436 | +$87,140,666 | NVCR, NUVA, MDRX, MDT, CORI | 13F-HR | 07 May 2018, 20:11 |
| Q4 2017 | 32 | $161,917,311 | +$47,705,045 | -$33,603,450 | +$14,101,595 | MDRX, PCRX, LH, NUVA, MDTXXXX | 13F-HR | 13 Feb 2018, 17:52 |
| Q3 2017 | 32 | $148,577,760 | +$47,335,200 | -$10,979,139 | +$36,356,061 | MDRX, NKTR, MDTXXXX, CORI, GILD | 13F-HR | 13 Nov 2017, 12:33 |
| Q2 2017 | 34 | $155,670,657 | +$31,735,753 | -$18,613,075 | +$13,122,678 | MDRX, NKTR, LH, PCRX, SPNC | 13F-HR | 07 Aug 2017, 18:30 |
| Q1 2017 | 28 | $145,234,025 | +$53,703,842 | -$15,827,671 | +$37,876,171 | MDRX, PCRX, NKTR, GILD, SPNC | 13F-HR | 12 May 2017, 15:55 |
| Q4 2016 | 25 | $134,103,476 | +$36,022,251 | -$95,083,868 | -$59,061,617 | ARIA, NXTM, HOLX, BIO, PCRX | Restatement | 16 Feb 2017, 14:04 |
| Q3 2016 | 37 | $315,266,649 | $0 | ELGX, NXTM, PDCO, ARIA, BIO | New Holdings | 09 Nov 2016, 17:44 | ||
| Q3 2016 | 37 | $315,266,649 | +$116,220,179 | -$36,309,149 | +$79,911,030 | ELGX, NXTM, PDCO, ARIA, BIO | 13F-HR | 08 Nov 2016, 18:01 |
| Q2 2016 | 26 | $255,109,624 | +$62,168,612 | -$89,611,976 | -$27,443,364 | ELGX, NXTM, IMPR, ARIA, DGX | 13F-HR | 12 Aug 2016, 17:49 |
| Q1 2016 | 21 | $285,699,000 | +$35,377,091 | -$92,012,945 | -$56,635,854 | ELGX, DGX, PDCO, NXTM, MDRX | 13F-HR | 13 May 2016, 20:04 |
| Q4 2015 | 31 | $759,795,000 | $0 | SPY, TLT, PDCO, DGX, ELGX | 13F-HR | 08 Feb 2016, 14:20 |